Ignite Creation Date:
2024-05-05 @ 11:28 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01337531
Status:
UNKNOWN
Last Update Posted:
2011-04-19
First Post:
2011-04-14
Brief Title:
Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome PCOS
Sponsor:
Genesis Center for Fertility Human Pre-Implantation Genetics
Organization:
Genesis Center for Fertility Human Pre-Implantation Genetics
Study Overview
Official Title:
Recombinant FSH Versus Highly Purified FSH in PCOS Patients Undergoing Control Ovarian Stimulation and IVF a Prospective Randomized Study
Status:
UNKNOWN
Status Verified Date:
2011-04
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Control ovarian stimulation responses pregnancy and miscarriage rates are indifferent when either recombinant or highly purified follicle stimulating hormone FSH is used
Detailed Description:
Patients will be randomized using sealed and numbered envelopes and will be assigned to receive a similar ovarian stimulation regime incorporating either Gonal-F or highly purified Fostimon as the hormonal analog Ovarian response using either of the two compounds pregnancy rates and miscarriage rates will be compared to define possible statistical significance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None